Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Harvard Business School
Johnson and Johnson
Mallinckrodt
Moodys

Last Updated: October 16, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LOFEXIDINE HYDROCHLORIDE

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Lofexidine Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000345 Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10 Completed National Institute on Drug Abuse (NIDA) Phase 1 1996-04-01 The purpose of this study is to assess the safety of lofexidine in the treatment of opiate-dependent individuals.
NCT00000354 Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3 Completed University of Pennsylvania Phase 1 1996-07-01 The purpose of this study is to determine the safety of lofexidine in the treatment of opiate withdrawal. Preliminary data will also be obtained to assess the ability of lofexidine to alleviate opiate withdrawal signs and symptoms.
NCT00000354 Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3 Completed National Institute on Drug Abuse (NIDA) Phase 1 1996-07-01 The purpose of this study is to determine the safety of lofexidine in the treatment of opiate withdrawal. Preliminary data will also be obtained to assess the ability of lofexidine to alleviate opiate withdrawal signs and symptoms.
NCT00000358 Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7 Completed University of Pennsylvania Phase 1 1969-12-31 The purpose of this study is to determine the safety of lofexidine in the treatment of opiate withdrawal. Preliminary data will also be obtained to assess the ability of lofexidine to alleviate opiate withdrawal signs and symptoms.
NCT00000358 Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7 Completed National Institute on Drug Abuse (NIDA) Phase 1 1969-12-31 The purpose of this study is to determine the safety of lofexidine in the treatment of opiate withdrawal. Preliminary data will also be obtained to assess the ability of lofexidine to alleviate opiate withdrawal signs and symptoms.
NCT00032942 Lofexidine for Opiate Withdrawal - 1 Completed Britannia Pharmaceuticals Ltd. Phase 3 2001-04-01 The purpose of this study is to evaluate lofexidine for opiate withdrawal.
NCT00032942 Lofexidine for Opiate Withdrawal - 1 Completed National Institute on Drug Abuse (NIDA) Phase 3 2001-04-01 The purpose of this study is to evaluate lofexidine for opiate withdrawal.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Lofexidine Hydrochloride

Condition Name

Condition Name for Lofexidine Hydrochloride
Intervention Trials
Opioid-Related Disorders 5
Opioid Dependence 4
Healthy 3
Substance-Related Disorders 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Lofexidine Hydrochloride
Intervention Trials
Opioid-Related Disorders 8
Substance Withdrawal Syndrome 7
Marijuana Abuse 3
Substance-Related Disorders 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Lofexidine Hydrochloride

Trials by Country

Trials by Country for Lofexidine Hydrochloride
Location Trials
United States 69
Israel 1
Singapore 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Lofexidine Hydrochloride
Location Trials
Texas 8
New York 7
Utah 6
California 6
Florida 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Lofexidine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Lofexidine Hydrochloride
Clinical Trial Phase Trials
Phase 4 1
Phase 3 5
Phase 2/Phase 3 1
[disabled in preview] 22
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Lofexidine Hydrochloride
Clinical Trial Phase Trials
Completed 24
Recruiting 2
Not yet recruiting 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Lofexidine Hydrochloride

Sponsor Name

Sponsor Name for Lofexidine Hydrochloride
Sponsor Trials
National Institute on Drug Abuse (NIDA) 21
US WorldMeds LLC 16
New York State Psychiatric Institute 3
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Lofexidine Hydrochloride
Sponsor Trials
NIH 21
Industry 17
Other 12
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
AstraZeneca
Dow
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.